Status:
RECRUITING
Study Looking at Biomarkers in Ovarian Cancer
Lead Sponsor:
University Health Network, Toronto
Conditions:
Gynecologic Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This is a sample study that will collect biological samples (blood, tumor tissue, ascites, and/or other fluids) from gynecological cancer patients for biomarker research. In addition, the results of t...
Eligibility Criteria
Inclusion
- Histological diagnosis of stage III or IV high grade serous ovarian, tubal or primary peritoneal cancer.
- Must be 18 years of age or older.
- Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1.
- Have a life expectancy greater than or equal to 6 months.
- Able to provide adequate informed consent.
- Willing to undergo blood or fluid collection and tumour biopsy
- Patients enrolled at the time of surgery must agree to have part of their tumour used for the purpose of the study.
- Archival tissue must be available for patients that are enrolled at the time of progression.
Exclusion
- Must not have early stage (I and II) high grade serous, tubal or primary peritoneal cancer.
- Must not have other tumour histology other than high grade serous.
- Must not have contraindication to tumour biopsy and/or blood sampling.
Key Trial Info
Start Date :
January 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 8 2028
Estimated Enrollment :
510 Patients enrolled
Trial Details
Trial ID
NCT03419689
Start Date
January 8 2018
End Date
June 8 2028
Last Update
December 4 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Victoria Regional Health Centre
Barrie, Ontario, Canada, L4M 6M2
2
Juravinski Cancer Centre
Hamilton, Ontario, Canada, L8V 5C2
3
Kingston Health Sciences Centre
Kingston, Ontario, Canada, K7L 2V7
4
London Health Sciences Centre
London, Ontario, Canada